Results 21 to 30 of about 10,024,591 (280)

Optimizing identification of major adverse limb and cardiovascular events among adults with peripheral artery disease in administrative data. [PDF]

J Vasc Surg
Objective: Atherosclerotic cardiovascular diseases (ASCVD) are the commonest cause of death. Peripheral artery disease (PAD) is an ASCVD that significantly increases risk of death and reduces quality of life; however, characterization of its consequences
Nassereldine H, Syme S, Shetty N, Iyer S, Hall DE, Reitz KM.   +5 more
europepmc   +2 more sources

Major Adverse Events in Patients with Peripheral Artery Disease after Endovascular Revascularization: A Retrospective Study [PDF]

, 2022
Objective: For peripheral artery disease (PAD) patients, after endovascular revascularization, it is crucial to manage associated factors that can affect the risk of major adverse events.
최모나, 고영국, Yong Sook Yang, Young-Guk Ko, Mona Choi, Mihui Kim, Ko, Young-Guk, Yang, Yong Sook, Choi, Mona, Kim, Mihui   +9 more
core   +2 more sources

Development of a biomarker panel for assessing cardiovascular risk in diabetic patients with chronic limb-threatening ischemia (CLTI): a prospective study

Cardiovascular Diabetology, 2023
Background Lower-extremity endovascular revascularization (LER) is often required for diabetic patients with chronic limb threatening ischemia (CLTI). During the post-revascularization period patients may unpredictably experience major adverse cardiac ...
Elisabetta Nardella, Federico Biscetti, Maria Margherita Rando, Andrea Leonardo Cecchini, Maria Anna Nicolazzi, Enrica Rossini, Flavia Angelini, Roberto Iezzi, Luis H. Eraso, Paul J. Dimuzio, Dario Pitocco, Massimo Massetti, Antonio Gasbarrini, Andrea Flex   +13 more
doaj   +1 more source

Antithrombotic Therapy in Peripheral Artery Disease: Current Evidence and Future Directions

Journal of Cardiovascular Development and Disease, 2023
Patients with peripheral artery disease (PAD) are at an increased risk of major adverse cardiovascular events, and those with disease in the lower extremities are at risk of major adverse limb events primarily driven by atherothrombosis.
Mario Enrico Canonico, Raffaele Piccolo, Marisa Avvedimento, Attilio Leone, Salvatore Esposito, Anna Franzone, Giuseppe Giugliano, Giuseppe Gargiulo, Connie N. Hess, Scott D. Berkowitz, Judith Hsia, Plinio Cirillo, Giovanni Esposito, Marc P. Bonaca   +13 more
doaj   +1 more source

Antithrombotic therapy in peripheral arterial disease

Frontiers in Cardiovascular Medicine, 2022
BackgroundPatients with peripheral arterial disease (PAD) are at increased risk for major adverse cardiovascular events (MACE) such as cardiovascular death, myocardial infarction, and stroke as well as major adverse limb events (MALE) such as amputation ...
Christine Espinola-Klein, Gerhard Weißer, Volker Schmitt, Volker Schmitt, Melanie Schwaderlapp, Thomas Munzel   +5 more
doaj   +1 more source

Major Adverse Limb Events and Mortality in Patients With Peripheral Artery Disease: The COMPASS Trial.

Journal of the American College of Cardiology, 2018
Jackie Bosch, Peter Verhamme, Keith Fox
exaly   +2 more sources

Cardiovascular risk factors and the risk of major adverse limb events in patients with symptomatic cardiovascular disease [PDF]

, 2020
Aim: To determine the relationship between non-high-density lipoprotein cholesterol (non-HDL-c), systolic blood pressure (SBP) and smoking and the risk of major adverse limb events (MALE) and the combination with major adverse cardiovascular events (MALE/
Visseren, FLJ, Bots, ML, Asselbergs, FW, De Borst, GJ, Hageman, SHJ, Dorresteijn, JAN, Westerink, J   +6 more
core   +2 more sources

Serum high mobility group box-1 levels associated with cardiovascular events after lower extremity revascularization: a prospective study of a diabetic population

Cardiovascular Diabetology, 2022
Background Peripheral arterial disease (PAD) is one of the most disabling cardiovascular complications of type 2 diabetes mellitus and is indeed associated with a high risk of cardiovascular and limb adverse events.
Maria Margherita Rando, Federico Biscetti, Andrea Leonardo Cecchini, Elisabetta Nardella, Maria Anna Nicolazzi, Flavia Angelini, Roberto Iezzi, Luis H. Eraso, Paul J. Dimuzio, Dario Pitocco, Antonio Gasbarrini, Massimo Massetti, Andrea Flex   +12 more
doaj   +1 more source

Risk Factors for Major Adverse Cardiovascular Events and Major Adverse Limb Events after Venous Thromboembolism: A Large Prospective Cohort Study

, 2022
International audienceBackground: There is an increased risk of arterial events including major adverse cardiovascular events (MACE) and major adverse limb events (MALE) after venous thromboembolism (VTE).
Nasr, Bahaa, Didier, Romain, Poulhazan, Elise, Noumegni, Steve Raoul, Couturaud, Francis, Bressollette, Luc, Mansourati, Vincent, Tromeur, Cécile, Hoffmann, Clément, Lacut, Karine, Mao, Raphael Le, Moreuil, Claire De, Guegan, Marie, Moigne, Emmanuelle Le, Roux, Pierre-Yves Le, Gentric, Jean-Christophe   +15 more
core   +1 more source

Urinary neutrophil gelatinase-associated lipocalin (NGAL) can potentially predict vascular complications and reliably risk stratify patients with peripheral arterial disease

Scientific Reports, 2022
Neutrophil gelatinase-associated lipocalin (NGAL) is expressed in atherosclerotic plaques and implicated in the development of cardiovascular diseases.
Mehroz Ehsan, Muzammil H. Syed, Abdelrahman Zamzam, Niousha Jahanpour, Krishna K. Singh, Rawand Abdin, Mohammad Qadura   +6 more
doaj   +1 more source